These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9833710)

  • 1. Thrombolysis with i.v. recombinant human tissue-type plasminogen activator in patients with bypass graft occlusion: a good adjunctive therapeutic mode (preliminary and case reports).
    Agresta F; Michelet I; Boni V; Tonietto G
    J Cardiovasc Surg (Torino); 1998 Oct; 39(5):551-5. PubMed ID: 9833710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human tissue-type plasminogen activator for thrombolysis in peripheral arteries and bypass grafts.
    Risius B; Graor RA; Geisinger MA; Zelch MG; Lucas FV; Young JR; Grossbard EB
    Radiology; 1986 Jul; 160(1):183-8. PubMed ID: 3086930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a prospective, randomized trial of surgery versus thrombolysis for occluded lower extremity bypass grafts.
    Comerota AJ; Weaver FA; Hosking JD; Froehlich J; Folander H; Sussman B; Rosenfield K
    Am J Surg; 1996 Aug; 172(2):105-12. PubMed ID: 8795509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and long-term results after intra-arterial thrombolysis of occluded lower extremity bypass grafts using recombinant tissue plasminogen activator for acute limb-threatening ischemia.
    Khosla S; Jain P; Manda R; Razminia M; Guerrero M; Trivedi A; Vidyarthi V; Elbazour M; Kunjummen B; Ahmed A; Lubell D
    Am J Ther; 2003; 10(1):3-6. PubMed ID: 12522513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter-directed thrombolysis for acute limb ischemia caused by native artery occlusion: an experience of a university hospital.
    Wongwanit C; Hahtapornsawan S; Chinsakchai K; Sermsathanasawadi N; Hongku K; Ruangsetakit C; Mutirangura P
    J Med Assoc Thai; 2013 Jun; 96(6):661-8. PubMed ID: 23951822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolytic therapy with recombinant human tissue-type plasminogen activator: a comparison of two doses.
    Risius B; Graor RA; Geisinger MA; Zelch MG; Lucas FV; Young JR
    Radiology; 1987 Aug; 164(2):465-8. PubMed ID: 3110860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is initial success of thrombolytic therapy with rt-PA in patients with lower limb ischemia durable? A long-term follow-up series.
    Geier B; Mumme A; Köster O; Marpe B; Hummel T; Asciutto G
    Vasa; 2007 May; 36(2):114-20. PubMed ID: 17708103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator.
    Berridge DC; Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR
    Thromb Haemost; 1989 Apr; 61(2):275-8. PubMed ID: 2501898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral artery and bypass graft occlusions.
    Graor RA; Risius B; Lucas FV; Young JR; Ruschhaupt WF; Beven EG; Grossbard EB
    Circulation; 1986 Sep; 74(3 Pt 2):I15-20. PubMed ID: 3091288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group.
    Braithwaite BD; Buckenham TM; Galland RB; Heather BP; Earnshaw JJ
    Br J Surg; 1997 May; 84(5):646-50. PubMed ID: 9171752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolysis with tissue-plasminogen activator: results with a high-dose transthrombus technique.
    Ward AS; Andaz SK; Bygrave S
    J Vasc Surg; 1994 Mar; 19(3):503-8. PubMed ID: 8126864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral artery and bypass graft thrombolysis with recombinant human tissue-type plasminogen activator.
    Graor RA; Risius B; Young JR; Denny K; Beven EG; Geisinger MA; Hertzer NR; Krajewski LP; Lucas FV; O'Hara PJ
    J Vasc Surg; 1986 Jan; 3(1):115-24. PubMed ID: 3079838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated thrombolysis using pulsed intra-thrombus recombinant human tissue type plasminogen activator (rt-PA).
    Buckenham TM; George CD; Chester JF; Taylor RS; Dormandy JA
    Eur J Vasc Surg; 1992 May; 6(3):237-40. PubMed ID: 1592125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot study.
    De Santis A; Moscatelli R; Catalano C; Iannetti A; Gigliotti F; Cristofari F; Trapani S; Attili AF
    Dig Liver Dis; 2010 Jun; 42(6):451-5. PubMed ID: 19819770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the Trellis Peripheral Infusion System for enhancement of rt-PA thrombolysis in acute lower limb ischemia.
    Tsetis DK; Katsamouris AN; Androulakakis Z; Chamalakis K; Kostas T; Chlapoutakis K; Gourtsoyiannis NC
    Cardiovasc Intervent Radiol; 2003; 26(6):572-5. PubMed ID: 15061187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Local thrombolysis in peripheral arterial occlusion].
    Hess H
    Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.
    Meyerovitz MF; Goldhaber SZ; Reagan K; Polak JF; Kandarpa K; Grassi CJ; Donovan BC; Bettmann MA; Harrington DP
    Radiology; 1990 Apr; 175(1):75-8. PubMed ID: 2107563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke: initial Israeli experience.
    Schwammenthal Y; Drescher MJ; Merzeliak O; Tsabari R; Bruk B; Feibel M; Hoffman C; Bakon M; Rotstein Z; Chapman J; Tanne D
    Isr Med Assoc J; 2004 Feb; 6(2):70-4. PubMed ID: 14986460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.